A randomized Phase III trial of durvalumab with chemotherapy and bevacizumab, followed by maintenance durvalumab, bevacizumab and olaparib in newly diagnosed advanced ovarian cancer (DUO-O): Updated trial endpoint and inclusion of China cohort (329)

Authors :: Aikou Okamoto
Jae-Weon Kim
Rutie Yin
Fabian Trillsch
Alexander Reuss
Carol Aghajanian
Maria Jesús Rubio-Pérez
Mehmet Ali Vardar
Giovanni Scambia
Anne Floquet
Gitte-Bettina Nyvang
Nicoletta Colombo
Mariusz Bidzinski
Christian Marth
Stéphanie Lheureux
Els Van Nieuwenhuysen
Paul Rugman
Jonathan Wessen
Philipp Harter
Source :: Gynecologic Oncology. 166:S170
Publication Year :: 2022
Publisher :: Elsevier BV, 2022.

Tools